The use of oral zuclopenthixol in the treatment of functional psychotic illness

An open study was undertaken to assess the efficacy and tolerance of oral zuclopenthixol in 40 patients with functional psychotic illness. Patients received zuclopenthixol dihydrochloride (25 mg tablets) in daily doses of 25 to 150 mg according to clinical response. Assessments were performed at wee...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 5(1987), 1 vom: 02., Seite 62-8
1. Verfasser: Bereen, F J (VerfasserIn)
Weitere Verfasser: Harte, F B, Maguire, J, Singh, A N
Format: Aufsatz
Sprache:English
Veröffentlicht: 1987
Zugriff auf das übergeordnete Werk:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Schlagworte:Journal Article Thioxanthenes Clopenthixol 982-24-1